Geminii offers a wearable device that can non-invasively monitor glucose levels and respond with treatment. This device emits harmless electromagnetic waves by decreasing the blood glucose and allowing patients to manage their symptoms. The technology addresses a substantial need in a way that is unexpected and without causing substantial negative side effects. There are large companies looking to expand their diabetes portfolio and the current trends seem to indicate a healthy amount of acquisition of small companies in the space.  The company will likely be able to raise funds for development from both private investors as well as national grants.

Venture Information
Stage: 
Product Development
Industry: 
Medical Devices
Technology or Science Area: 
Electromagnetic Treatment of Diabetes
Type of Product: 
Medical device plus software
Market: 
Diabetic patients and people with obesity
Funding Round: 
Seed
Company Information
Founders: 
Calvin Carter
Walter Carter
Sunny Huang